The San Diego-based biotech said Wednesday during an earnings call that it's moving directly to a Phase 3 study of its drug, ...

CVS Caremark, one of the largest pharmacy benefit managers in the country, agreed to pay at least $45 million to the state of ...

Merck laid off around 75 to 80 people in its early research division this week. The move comes amid a series of layoffs from ...

One of largest studies using exoskeletons for rehab in children with cerebral palsy demonstrated a limited gain in gross ...

CVS Caremark, one of the largest PBMs, agreed to pay at least $45 million to the state of Illinois to settle allegations that ...

Cell and gene therapy developers must demonstrate ethical leadership on behalf of blood and tissue donors while regulators ...

Jiankui He, who sparked a global uproar in 2018 when he revealed he had created gene-edited children, is out on his own after ...

Sen. Bob Casey Jr. (D-Pa.) will introduce legislation Wednesday to strengthen and expand a critical part of the ...

Sage Therapeutics said an experimental pill failed to quell involuntary muscle shaking in patients with a neurological ...

Pfizer reported positive data for its gene therapy for hemophilia A, and yet early excitement about such therapy has been tempered by questions over durability and demand.

The U.S. is just beginning to experience the full impact of its aging population. Regrettably, its health care system and workforce are inadequately prepared to handle the surge of geriatric patients.